M. Yood

发表

Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.

M. Manos, S. Taplin, S. Weinmann, 2005, Journal of the National Cancer Institute.

Patient Characteristics and Participation in a Genetic Study

S. Oliveria, D. Lanfear, K. Wells, 2014, Journal of Investigative Medicine.

Racial differences in the presentation and surgical management of breast cancer.

S. Nathanson, V. Velanovich, M. Yood, 1999, Surgery.

Under Utilization of Surveillance Mammography among Older Breast Cancer Survivors

Chyke A Doubeni, T. Lash, D. Buist, 2008, Journal of General Internal Medicine.

Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.

J. Berlin, A. Grothey, F. Kabbinavar, 2009, The oncologist.

Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care.

D. Buist, T. Field, L. Ichikawa, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer

T. Lash, T. Field, A. Geiger, 2014, Breast Cancer Research and Treatment.

Recommendations for Care Related to Follow-Up of Abnormal Cancer Screening Tests

M. Manos, S. Taplin, C. Somkin, 2005, Evaluation & the health professions.

Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer.

M. Manos, W. Barlow, S. Taplin, 2005, Journal of the National Cancer Institute. Monographs.

Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm

M. Manos, U. Iloeje, C. Quesenberry, 2007, Journal of viral hepatitis.

Prescription drug use in pregnancy.

Robert L Davis, Richard Platt, Marsha A Raebel, 2004, American journal of obstetrics and gynecology.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy

R. Platt, Robert L. Davis, S. Andrade, 2007, Pharmacoepidemiology and drug safety.

Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER

H. Rugo, Lisa I. Wang, I. C. Tudor, 2011, Clinical Cancer Research.

Safety of bevacizumab (BV) among patients (pts) receiving first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): Preliminary results from a larger registry in the U.S

R. Robles, A. Grothey, F. Kabbinavar, 2005 .

Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers.

W. Chow, U. Mujumdar, K. Wells, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer

H. Rugo, D. Tripathy, D. Yardley, 2013, Breast Cancer Research and Treatment.

Using prescription claims data for drugs available over‐the‐counter (OTC)

K. Rothman, K. Wells, H. Jick, 2007, Pharmacoepidemiology and drug safety.

Delayed radiotherapy for breast cancer patients in integrated delivery systems.

T. Lash, D. Buist, T. Field, 2009, The American journal of managed care.

Original article Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia

S. Oliveria, M. Yood, M. Cziraky, 2012 .

Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia

S. Oliveria, M. Yood, M. Cziraky, 2012, Current medical research and opinion.

Administrative data used to identify patients with irritable bowel syndrome.

Sarah J. Beaton, J. Gurwitz, R. Davis, 2008, Journal of clinical epidemiology.

Bipolar disorder detection, ascertainment, and treatment: primary care physician knowledge, attitudes, and awareness.

P. Stang, K. Wells, M. Yood, 2006, Primary care companion to the Journal of clinical psychiatry.

The impact of NSAID or COX‐2 inhibitor use on the initiation of antihypertensive therapy

K. Wells, C. Johnson, M. Yood, 2006, Pharmacoepidemiology and drug safety.

Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis

H. Feigelson, G. Divine, L. Habel, 2017, Cancer Causes & Control.

B. McCarthy, R. E. Ward, M. Yood, 1996, Health services research.

Discontinuation and dose modification of imatinib in clinical practice

S. Oliveria, V. Willey, M. Yood, 2007 .

Screening mammography use: the importance of a population perspective.

B. McCarthy, M. Yood, C. MacWilliam, 1996, American journal of preventive medicine.

Comorbidities and cardiovascular disease risk in older breast cancer survivors.

A. Geiger, V. Quinn, A. Kamineni, 2014, The American journal of managed care.

The CoPrescription of Contraindicated Drugs With Statins: Continuing Potential for Increased Risk of Adverse Events

P. Stang, S. Oliveria, M. Yood, 2007, American journal of therapeutics.

Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence.

D. Buist, T. Field, Jessica Chubak, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Statin use and risk of hepatocellular carcinoma in a U.S. population.

K. McGlynn, G. Divine, K. Wells, 2014, Cancer epidemiology.

Incident depression in patients diagnosed with multiple sclerosis: a multi‐database study

S. Niemcryk, S. Jick, M. Yood, 2020, European journal of neurology.

Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study.

S. Niemcryk, S. Jick, M. Yood, 2020, Multiple sclerosis and related disorders.

Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries

S. Niemcryk, S. Jick, M. Yood, 2019, Journal of Neurology.

A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.

Timothy L Lash, Ann M Geiger, Soe Soe Thwin, 2010, Journal of clinical epidemiology.

Validity of Eight Integrated Healthcare Delivery Organizations' Administrative Clinical Data to Capture Breast Cancer Chemotherapy Exposure

Roy Pardee, Catherine A. McCarty, Adedayo A. Onitilo, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Survival of patients with HER2+ metastatic breast cancer and use of trastuzumab following progression: analysis of RegistHER.

M. Birkner, H. Rugo, S. Paik, 2009 .

C-B2-01: Cardiotoxic Chemotherapy is Associated with Increased Heart Failure Risk Among Women with Breast Cancer in the Cancer Research Network

L. Allen, C. McCarty, H. Feigelson, 2011, Clinical Medicine & Research.

Renal impairment after chemotherapy in lung (LC), colorectal (CRC), and breast cancer (BC) patients (pts) from the Henry Ford Health System (HFHS) tumor registry.

S. Oliveria, D. Casso, K. Wells, 2012 .

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer

H. Rugo, D. Tripathy, D. Yardley, 2014, Breast Cancer Research and Treatment.

Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study

H. Rugo, D. Tripathy, D. Yardley, 2012, Breast Cancer Research and Treatment.

First-line treatment patterns and clinical outcomes in patients with HER2-positive and hormone receptor-positive metastatic breast cancer from registHER.

H. Rugo, D. Tripathy, D. Yardley, 2013, The oncologist.

Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer.

Timothy L Lash, Virginia P Quinn, Ann M Geiger, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival Among Copd Patients Using Fluticasone/Salmeterol in Combination Versus Other Inhaled Steroids and Bronchodilators Alone

J. Soriano, Leila S. Nelson, K. Davis, 2007, COPD.

Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators.

K. Davis, David P. Miller, M. Yood, 2010, Primary care respiratory journal : journal of the General Practice Airways Group.

Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: a descriptive report.

S. Oliveria, V. Willey, M. Yood, 2010, Clinical therapeutics.

Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy.

P. Stang, S. Oliveria, B. McCarthy, 2006, American heart journal.

Routine Surveillance Care After Cancer Treatment With Curative Intent

G. Chase, L. Schultz, J. Lafata, 2005, Medical care.

Mammography surveillance and mortality in older breast cancer survivors.

T. Lash, D. Buist, T. Field, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of Guideline Recommended Follow-Up Care in Cancer Survivors: Routine or Diagnostic Indications?

G. Cooper, G. Chase, L. Schultz, 2006, Medical care.

Breast cancer treatment of older women in integrated health care settings.

T. Lash, D. Buist, T. Field, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influenza immunization in a managed care organization

B. McCarthy, M. Yood, M U Yood, 1998, Journal of general internal medicine.

Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study

L. Allen, K. Goddard, C. McCarty, 2012, Journal of the National Cancer Institute.

Redesigning Primary Care Processes to Improve the Offering of Mammography: The Use of Clinic Protocols by Nonphysicians

M. Young, B. McCarthy, E. Boohaker, 2006, Journal of General Internal Medicine.

Redesigning Primary Care Processes to Improve the Offering of Mammography. The use of Clinic Protocols by Nonphysicians.

M. Young, B. McCarthy, E. Boohaker, 1997 .

Implementation of systems strategies for breast and cervical cancer screening services in health maintenance organizations.

S. Taplin, L. Solberg, C. Somkin, 2003, The American journal of managed care.

Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?

M. Manos, W. Barlow, S. Taplin, 2005, Journal of the National Cancer Institute.

The incidence of diabetes in atypical antipsychotic users differs according to agent—results from a multisite epidemiologic study

J. Newcomer, S. Oliveria, V. Willey, 2009, Pharmacoepidemiology and drug safety.

Long-term Safety of Radiotherapy and Breast Cancer Laterality in Older Survivors

A. Geiger, V. Quinn, A. Kamineni, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Use of prescription medications with a potential for fetal harm among pregnant women

Richard Platt, A. Morse, J. Gurwitz, 2006, Pharmacoepidemiology and drug safety.

Use of cyclo‐oxygenase 2 inhibitors (COX‐2) and prescription non‐steroidal anti‐inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX‐2 cardiovascular profile

Kenneth J Rothman, Susan A Oliveria, K. Rothman, 2006, Pharmacoepidemiology and drug safety.

Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer

N. Keating, S. K. Van Den Eeden, D. Aaronson, 2017, The Journal of urology.

Long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer

Virginia P. Quinn, Timothy L. Lash, Heather Taffet Gold, 2013, Breast Cancer Research and Treatment.

Mortality impact of less-than-standard therapy in older breast cancer patients.

T. Lash, D. Buist, T. Field, 2008, Journal of the American College of Surgeons.

Inadequate follow-up of abnormal mammograms.

B D McCarthy, C. C. Johnson, M. Rebner, 1996, American journal of preventive medicine.

Colon polyp recurrence in a managed care population.

P. Stang, S. Oliveria, K. Wells, 2003, Archives of internal medicine.

Potential Drug–Drug Interactions in the Outpatient Setting

Richard Platt, Marsha A Raebel, John R Horn, 2006, Medical Care.

Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta‐blockers during pregnancy

R. Davis, R. Platt, S. Andrade, 2011, Pharmacoepidemiology and drug safety.

Incidence of cancer in a population-based cohort of patients with type 2 diabetes

S. Oliveria, M. Yood, C. Koro, 2009 .

Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer.

M. Menon, A. Tewari, E. Wagner, 2009, Urology.

Influence of NSAID Use Among Colorectal Cancer Survivors on Cancer Outcomes

M. Jankowski, C. Johnson, S. Rolnick, 2017, American journal of clinical oncology.

Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study

T. Lash, D. Buist, T. Field, 2014, Breast Cancer Research and Treatment.

Cancer incidence among patients treated with antidiabetic pharmacotherapy

S. Oliveria, M. Yood, C. Koro, 2008 .

Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy

C. Gross, S. Oliveria, K. Wells, 2012, Pharmacoepidemiology and drug safety.

Using probabilistic corrections to account for abstractor agreement in medical record reviews.

T. Lash, D. Buist, T. Field, 2007, American journal of epidemiology.

Race and differences in breast cancer survival in a managed care population.

C. C. Johnson, J. Abrams, A. Blount, 1999, Journal of the National Cancer Institute.

Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer

L. Allen, E. Wagner, A. Onitilo, 2014, Medical care.

Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER

H. Rugo, J. Magidson, D. Tripathy, 2014, British Journal of Cancer.

Processes of care in cervical and breast cancer screening and follow-up--the importance of communication.

M. Manos, S. Taplin, C. Somkin, 2004, Preventive medicine.

Economic Burden of Cancer in the United States: Estimates, Projections, and Future Research

Angela Mariotto, Nikki A. Hawkins, Deanna Kepka, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Infections in patients diagnosed with multiple sclerosis: A multi-database study.

S. Niemcryk, S. Jick, M. Yood, 2020, Multiple sclerosis and related disorders.

Treatment and Referral Patterns for Colorectal Cancer

P. Stang, S. Oliveria, M. Yood, 2004, Medical care.

Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer

S. K. Van Den Eeden, A. Freedman, D. Aaronson, 2018, Cancer Causes and Control.

Resistance to imatinib among patients in chronic phase (CP) of chronic myelogenous leukemia (CML) in clinical practice

S. Oliveria, V. Willey, M. Yood, 2008 .

Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta‐blockers during pregnancy

R. Davis, R. Platt, S. Andrade, 2011, Pharmacoepidemiology and drug safety.

Evaluation of factors potentially associated with inadequate follow‐up of mammographic abnormalities

N. Janz, B. McCarthy, C. Johnson, 1996, Cancer.

Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators.

K. Davis, David P. Miller, M. Yood, 2010, Primary care respiratory journal : journal of the General Practice Airways Group.

What do medical records tell us about potentially harmful co-prescribing?

L. Schultz, M. Raebel, David H. Smith, 2007, Joint Commission journal on quality and patient safety.

Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer

S. K. Van Den Eeden, A. Freedman, D. Aaronson, 2018, Cancer Causes & Control.